Company / Revenue
GERON CORP Revenue History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$237.0K
FY2023
5-year range
$237.0K / $1.1M
FY2019-FY2023
Trend
-60.2%
vs FY2022
Sector context
#147 of 155
Health Care
What the data says
Among 155 Health Care companies, GERON CORP is in the bottom 5% for revenue. Revenue has fluctuated over the past 9 years, ranging from $237,000 in FY2023 to $36M in FY2017.
Based on SEC 10-K filings.
$237,000 in FY2023 with a 5-year CAGR of -47.9%.
Declined from $460,000 to $237,000 over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -39.4%
- 5-Year CAGR
- -47.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 155This company $237.0K Sector average $4.5B
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -47.9%, indicating a declining trend.
- In FY2023, revenue decreased 60.2% year-over-year.
- Ranks #147 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $237.0K | -60.2% |
| FY2022 | $596.0K | +29.6% |
| FY2021 | $460.0K | -56.8% |
| FY2020 | $1.1M | +0.1% |
| FY2019 | $1.1M | -82.7% |
| FY2018 | $6.2M | -83.1% |
| FY2017 | $36.4M | +3054.5% |
| FY2016 | $1.2M | -10.1% |
| FY2015 | $1.3M | +170.7% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026